Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3041% below fair value
$18.75+0.61 (+3.36%)
Close on Nov 13, 2026Market cap $3.23BP/E 8.9Yield –
Acadia Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Acadia Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was 30.1%. For fiscal 2025 it was 36.5%, against 23.6% the year before. The highest annual figure on record is 36.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.5% | +12.8 |
| FY2024 | Dec 31, 2024 | 23.6% | +32.1 |
| FY2023 | Dec 31, 2023 | -8.4% | +33.3 |
| FY2022 | Dec 31, 2022 | -41.8% | −7.1 |
| FY2021 | Dec 31, 2021 | -34.7% | +29.1 |
| FY2020 | Dec 31, 2020 | -63.7% | +5.6 |
| FY2019 | Dec 31, 2019 | -69.4% | +40.2 |
| FY2018 | Dec 31, 2018 | -109.6% | +122.2 |
| FY2017 | Dec 31, 2017 | -231.7% | +1334.2 |
| FY2016 | Dec 31, 2016 | -1565.9% | +268012.7 |
| FY2015 | Dec 31, 2015 | -269578.7% | −192516.2 |
| FY2014 | Dec 31, 2014 | -77062.5% | −73748.3 |
| FY2013 | Dec 31, 2013 | -3314.2% | −2889.4 |
| FY2012 | Dec 31, 2012 | -424.9% | +676.5 |
| FY2011 | Dec 31, 2011 | -1101.4% | −1137.3 |
| FY2010 | Dec 31, 2010 | 35.9% | +741.4 |
| FY2009 | Dec 31, 2009 | -705.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 15.6% | −10.1 |
| Q2 FY2026 | Jun 30, 2026 | 10.2% | +0.1 |
| Q1 FY2026 | Mar 31, 2026 | 1.4% | −6.4 |
| Q4 FY2025 | Dec 31, 2025 | 96.3% | +41.0 |
| Q3 FY2025 | Sep 30, 2025 | 25.8% | +12.7 |
| Q2 FY2025 | Jun 30, 2025 | 10.1% | −3.7 |
| Q1 FY2025 | Mar 31, 2025 | 7.8% | −0.3 |
| Q4 FY2024 | Dec 31, 2024 | 55.4% | +35.5 |
| Q3 FY2024 | Sep 30, 2024 | 13.1% | +43.9 |
| Q2 FY2024 | Jun 30, 2024 | 13.8% | +13.1 |
| Q1 FY2024 | Mar 31, 2024 | 8.0% | +44.4 |
| Q4 FY2023 | Dec 31, 2023 | 19.8% | +50.4 |
| Q3 FY2023 | Sep 30, 2023 | -30.8% | −10.0 |
| Q2 FY2023 | Jun 30, 2023 | 0.7% | +25.9 |
| Q1 FY2023 | Mar 31, 2023 | -36.3% | +61.6 |
| Q4 FY2022 | Dec 31, 2022 | -30.6% | +2.4 |
| Q3 FY2022 | Sep 30, 2022 | -20.8% | −9.8 |
| Q2 FY2022 | Jun 30, 2022 | -25.3% | +12.8 |
| Q1 FY2022 | Mar 31, 2022 | -97.9% | −35.6 |
| Q4 FY2021 | Dec 31, 2021 | -33.0% | +22.2 |
| Q3 FY2021 | Sep 30, 2021 | -11.0% | +59.2 |
| Q2 FY2021 | Jun 30, 2021 | -38.1% | +0.2 |
| Q1 FY2021 | Mar 31, 2021 | -62.4% | +35.4 |
| Q4 FY2020 | Dec 31, 2020 | -55.2% | −1.2 |
| Q3 FY2020 | Sep 30, 2020 | -70.2% | −25.8 |
| Q2 FY2020 | Jun 30, 2020 | -38.3% | +27.8 |
| Q1 FY2020 | Mar 31, 2020 | -97.7% | +37.8 |
| Q4 FY2019 | Dec 31, 2019 | -53.9% | +56.0 |
| Q3 FY2019 | Sep 30, 2019 | -44.4% | +62.2 |
| Q2 FY2019 | Jun 30, 2019 | -66.0% | +44.8 |
| Q1 FY2019 | Mar 31, 2019 | -135.5% | −24.4 |
| Q4 FY2018 | Dec 31, 2018 | -109.9% | +48.2 |
| Q3 FY2018 | Sep 30, 2018 | -106.6% | +76.8 |
| Q2 FY2018 | Jun 30, 2018 | -110.9% | +110.4 |
| Q1 FY2018 | Mar 31, 2018 | -111.1% | +463.6 |
| Q4 FY2017 | Dec 31, 2017 | -158.1% | +499.8 |
| Q3 FY2017 | Sep 30, 2017 | -183.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -221.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -574.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -657.9% | – |
See a number that looks wrong?